Transaction Advisory Services

  • Share

M&A and Capital and Debt Advisory

M&A Advisory 
Drawing on industry knowledge and leveraging an extensive global network, our M&A Advisory team provides sector-focused advice on the sale process from strategic positioning to close, and we help execute acquisitions, alliances and mergers. We also advise C-suite executives and boards on evaluating strategic alternatives in the context of transactions. We assist clients with the following transaction structures:

  • Sell-side
  • Buy-side
  • Division/subsidiary spin-offs and divestitures
  • Joint ventures and strategic alliances
  • Going private transactions
  • Employee stock ownership plans (ESOPs)
  • LBOs and recapitalizations
  • Cross-border deals
  • Distressed M&A (363 Sales)

Services are offered through Ernst & Young Capital Advisors, LLC, a broker-dealer affiliate of Ernst & Young LLP and member of FINRA. www.finra.org.

Capital and Debt Advisory 
Our Capital and Debt Advisory team helps organizations raise debt and equity capital, advise on capital structure transactions and execute complex balance sheet restructurings.  The team has decades of experience guiding clients through capital events, and it understands the dynamics of every layer of the capital structure. We can help you secure financing across the capital structure for the following capital events:

 

  • Acquisition financing
  • LBOs
  • Growth financings
  • Refinancings
  • Recapitalizations
  • Amendments
  • Consents and exchanges
  • Bankruptcies

Services are offered through Ernst & Young Capital Advisors, LLC, a broker-dealer affiliate of Ernst & Young LLP and member of FINRA. www.finra.org.

Contact us

EY - Jim Carter

James W. Carter
President and CEO–
Ernst & Young Capital Advisors, LLC

Contact a member of our EY Capital Advisors Team.

Connect with us

EY - Middle-market deals to fuel M&A rebound

Middle-market deals to fuel M&A rebound

Our 11th Capital Confidence Barometer predicts healthy growth for M&A globally, which should take the market back to levels seen before the financial crisis.

EY - What’s in store for biotech dealmaking in 2014?

What’s in store for biotech dealmaking in 2014?

Watch Benjamin Perkins take a deep dive into what life sciences companies are expecting in 2014.